The coherence between tumor-intrinsic metabolic phenotypes (lactate/ECAR), decreased glycolytic enzyme expression, and TIA1–mRNA association suggests that TIA1-dependent condensates are a hypothesis-generating axis rather than a validated therapeutic target at present. The gene discussed is TIA1; the disease is neoplasm.